NASDAQ:YDES YD Bio (YDES) Stock Price, News & Analysis $6.34 +0.24 (+3.93%) As of 12:40 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About YD Bio Stock (NASDAQ:YDES) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get YD Bio alerts:Sign Up Key Stats Today's Range$6.00▼$6.4450-Day Range$2.25▼$8.1152-Week Range$1.70▼$22.00Volume14,436 shsAverage Volume146,323 shsMarket Capitalization$448.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview YD Bio Limited is a biotechnology company focused on the development of DNA methylation-based cancer detection technologies and ophthalmologic innovations. The company also provides clinical trial support and related research services. YD Bio Limited is headquartered in Taipei, Taiwan, and its ordinary shares trade on the Nasdaq Global Market under the ticker symbol YDES. Read More YD Bio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreYDES MarketRank™: 0.84658866833 of 5 starsYD Bio scored higher than 17% of companies evaluated by MarketBeat, and ranked 829th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingYD Bio has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageYD Bio has received no research coverage in the past 90 days.Read more about YD Bio's stock forecast and price target. Earnings and ValuationN/AProj. Earnings GrowthN/A Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.25% of the float of YD Bio has been sold short.Short Interest Ratio / Days to CoverYD Bio has a short interest ratio ("days to cover") of 0.24, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in YD Bio has recently increased by 312.78%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldYD Bio does not currently pay a dividend.Dividend GrowthYD Bio does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.47 News SentimentYD Bio has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for YD Bio this week, compared to 1 article on an average week. Company Ownership2.1 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $12,183.00 in company stock, which represents 0.0027% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, YD Bio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,183.00 in company stock and sold $0.00 in company stock.Percentage Held by InstitutionsYD Bio has minimal institutional ownership at this time.Read more about YD Bio's insider trading history. Receive YDES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YD Bio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. YDES Stock News HeadlinesYD Bio Limited (NASDAQ:YDES) Shares Shorted: Short Interest Up 312.8% in SeptemberOctober 11 at 12:42 PM | americanbankingnews.comYD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor AssessmentOctober 6, 2026 | globenewswire.comMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a contest offering its biggest holders a seat at dinner with the President. It's also about 97% below its peak. Because a memecoin doesn't benefit from good policy. It benefits from attention. The real winners of a pro-crypto Washington are the projects with actual businesses underneath them. Ones that get more valuable as rules get clearer, institutions get comfortable, and more money flows into the market.October 14 at 1:00 AM | Crypto 101 Media (Ad)YD Bio Ltd (YDES)September 1, 2026 | finance.yahoo.comYD Bio Files First-Half 2026 Results, Reports Improved Equity PositionSeptember 1, 2026 | tipranks.comYD Bio Limited Reports First-Half 2026 Financial Results, 315% Revenue Growth and Net Income of $6.7 MillionAugust 31, 2026 | quiverquant.comQYD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026August 31, 2026 | globenewswire.comYDES - YD Bio LimitedAugust 26, 2026 | seekingalpha.comSee More Headlines YDES Stock Analysis - Frequently Asked Questions How have YDES shares performed this year? YD Bio's stock was trading at $12.19 at the beginning of 2026. Since then, YDES shares have decreased by 48.4% and is now trading at $6.2950. How were YD Bio's earnings last quarter? YD Bio Limited (NASDAQ:YDES) released its quarterly earnings data on Tuesday, September, 1st. The biotechnology company reported $0.05 EPS for the quarter. The biotechnology company earned $0.42 million during the quarter. How do I buy shares of YD Bio? Shares of YDES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/01/2026Today10/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 YDES's financial health is in the Green zone, according to TradeSmith. YDES has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:YDES CIK2011674 Webwww.ydesgroup.com Phone(822) 546-1611FaxN/AEmployees15Year Founded2025Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares70,790,000Free FloatN/AMarket Cap$449.16 million OptionableN/A Beta-1.55 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:YDES) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YD Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share YD Bio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
